Cravath’s New York Office Moves to Two Manhattan West
February 12, 2024
Cravath partner Minh Van Ngo served as contributing editor of Lexology Panoramic’s “Financial Services M&A” guide, which was published in February 2024 and examines key developments and trends in global M&A activity in the financial services sector. The introduction outlines the macroeconomic headwinds and geopolitical uncertainty impacting global dealmaking. Minh also authored the U.S. chapter, which provides an overview of the current market climate for financial services M&A in the United States and details the legal and regulatory framework, pricing and financing and strategic considerations for deals.
Deals & Cases
March 09, 2023
On March 8, 2023, Airspan Networks Holdings (“Airspan”), a provider of software and hardware for 5G networks and a pioneer in end‑to‑end Open RAN solutions that provide interoperability with other vendors, announced the signing of definitive agreements for the sale of Mimosa Networks, Inc. (“Mimosa”) to Radisys Corporation (“Radisys”), a wholly owned subsidiary of Jio Platforms Limited, which is a subsidiary of Reliance Industries Limited, on a debt free, cash free basis. Cravath is representing Airspan in connection with the transaction.
Deals & Cases
January 30, 2023
On January 20, 2023, ViewRay, Inc. (“ViewRay”), which designs, manufactures and markets the MRIdian® MRI‑Guided Radiation Therapy System, announced that it has reached an agreement with Hudson Executive Capital LP (“HEC”), a New York City‑based value‑oriented investor, to appoint a senior investment analyst and representative of HEC as an observer of the ViewRay Board of Directors (the “Board”), effective as of January 20, 2023. ViewRay has also agreed that the Board will appoint that observer to fill any vacancy on the Board arising during the term of the agreement. In connection with this announcement, ViewRay has also entered into a cooperation agreement with HEC, which currently owns approximately 8.7% of the Company’s outstanding common stock. Pursuant to its agreement with ViewRay, HEC has agreed to customary standstill and voting commitments, among other provisions. Cravath is representing ViewRay in connection with the agreement.
Deals & Cases
March 09, 2022
On March 9, 2022, ViewRay, Inc. (“ViewRay”), which designs, manufactures and markets the MRIdian® MRI‑Guided Radiation Therapy System, announced that it has reached an agreement with Hudson Executive Capital LP (“HEC”), a New York City‑based value‑oriented investor, to appoint an independent director to the ViewRay Board of Directors, effective as of March 8, 2022. In addition, ViewRay has retained a representative of HEC as a consultant to work with the Company to enhance shareholder returns and ViewRay has agreed to consider that consultant as a candidate for election to the Board at the 2023 annual stockholder meeting. In connection with this announcement, ViewRay has entered into a cooperation agreement with HEC, which currently owns approximately 8.8% of the Company’s outstanding common stock. Pursuant to its agreement with ViewRay, HEC has agreed to customary standstill and voting commitments, among other provisions. Cravath is representing ViewRay in connection with the agreement.
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2024 Cravath, Swaine & Moore LLP.